My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

44.68 +0.14 (+0.31%)
Official Closing Price Updated: 7:00 PM EDT, Oct 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,379,397
Open 44.82
Bid (Size) 44.78 (2)
Ask (Size) 44.85 (21)
Prev. Close 44.54
Today's Range 44.53 - 45.19
52wk Range 42.96 - 63.33
Shares Outstanding 2,222,113,553
Dividend Yield 5.55%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Value Stocks with Warning Signs
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) Offers a High Dividend Yield and Strong Profitability
Bristol Myers Squibb (BMY) offers a high 5.42% dividend yield with strong profitability and a decade of consistent payouts, making it a top stock for income investors. 
Via Chartmill

Performance

YTD
-21.3%
-21.3%
1 Month
-5.4%
-5.4%
3 Month
-7.9%
-7.9%
6 Month
-11.5%
-11.5%
1 Year
-15.4%
-15.4%

More News

Read More
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) Presents a Strong Value Investment Case
Via Chartmill
Price Over Earnings Overview: Bristol-Myers Squibb
Via Benzinga
These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap
Via Benzinga
Bristol Myers To Sell Plaque Psoriasis Drug For Over 80% Discount Starting In 2026
Via Stocktwits
What's going on in today's session: S&P500 movers
Via Chartmill
Nanobiotix Stock Soars on Breakthrough Esophageal Cancer Data, Igniting Biotech Hopes
Via MarketMinute
Healthcare Sector Defies Headwinds, Rallies on Wall Street Amidst Shutdown and Jobs Data
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
In today's session, there are S&P500 stocks with remarkable trading volume.
Via Chartmill
Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday?
Via Benzinga
Why Is Bristol-Myers Squibb (BMY) Stock Rocketing Higher Today
Via StockStory
Topics Artificial Intelligence
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields
Via Benzinga
Bristol Myers Squibb’s Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer’s Disease
From Bristol Myers Squibb
Via Business Wire
Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
Via MarketMinute
Topics Economy Government World Trade
Trump's Plan To Lower U.S. Drug Prices Faces Big Test
Via Investor's Business Daily
Topics Government
Merus N.V. Soars on $8 Billion Genmab Acquisition, Propelled by Oncology Pipeline Successes
Via MarketMinute
Pharma Lobby Announces New Website To Connect Patients With Manufacturer-Direct Purchase Program
Via Stocktwits
Topics Government
Johnson & Johnson's Hypothetical Rally: A Look at Potential 2025 Valuation Drivers
Via MarketMinute
Topics Economy Intellectual Property
Immuneering Corporation's Stock Takes a Hit Amidst Funding Round Despite Promising Clinical Data
Via MarketMinute
Trump's 100% Drug Tariffs 'A Meaningful Commercial Hit' For Americans, But 'Loopholes' Could Blunt Impact, Says Analyst
Via Benzinga
Topics Government World Trade
Global Markets Brace for Impact as New U.S. Tariffs Escalate Trade Tensions Amidst Geopolitical Volatility
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet
Via Benzinga
Topics Government World Trade
Bristol Myers Squibb Builds on Eliquis® (apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu® (deucravacitinib)
From Bristol Myers Squibb
Via Business Wire
The Smartest Dividend Stock to Buy With $1,000 Right Now
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 44.68
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 10/09/25 07:00 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 99.28B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 99B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.